Naresuan University Hospital is a primary teaching hospital of the Faculty of Medicine Naresuan University, located on the campus of Naresuan University in Phitsanulok Province, Thailand. The hospital is designed as the super tertiary care medical center in the lower northern region of Thailand.

There are 400 beds in Naresuan University Hospital.

During the past decade, Naresuan University Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Naresuan University Hospital" #1 sponsor was "Arbutus Biopharma Corporation" with 1 trials, followed by "Arcus Biosciences, Inc." with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "Ionis Pharmaceuticals, Inc." with 1 trials sponsored and "United Therapeutics" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Naresuan University Hospital" #1 collaborator was "Gilead Sciences" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Naresuan University Hospital" are "Beta Thalassemia Intermedia" (1 trials), "Chronic Hepatitis" (1 trials), "Head and Neck Neoplasms" (1 trials), "Lung Cancer" (1 trials) and "Non Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Naresuan University Hospital" in a lesser frequency.

Most popular intervention types in "Naresuan University Hospital" are "Drug" (5 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "AB-836" (1 trials), "Carboplatin" (1 trials), "Dinutuximab" (1 trials), "Domvanalimab" (1 trials) and "Irinotecan" (1 trials). Other intervention names were less common.

The vast majority of trials in "Naresuan University Hospital" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Naresuan University Hospital". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Naresuan University Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Naresuan University Hospital, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".